Rapid weight loss is often viewed as proof that GLP-1 medications are working. But in some cases, worsening nausea, extreme fullness, and food intolerance may signal gastroparesis rather than successful appetite control.
As tirzepatide and semaglutide drive larger weight-loss results, questions about muscle preservation and body composition are becoming increasingly important in obesity medicine.
A major clinical trial found that tirzepatide produced greater average weight loss than semaglutide over 72 weeks. Here’s what researchers believe explains the difference between these two leading obesity medications.
Rapid weight loss from GLP-1 medications like Ozempic and Wegovy may lead to muscle loss and a flattened glute appearance known as “Ozempic butt.” Learn how resistance training, protein intake, and targeted glute exercises can help preserve muscle and support healthier weight loss.
GLP-1 drugs have transformed obesity treatment, with tirzepatide now leading in effectiveness. Here’s what the latest 2026 evidence reveals about safety, results, and future therapies.
Can you lose weight on Wegovy without dieting or exercise? This evidence-based guide explains how semaglutide works, its limits, and what ensures long-term success.
This guide explains how GLP-1 drugs work, their benefits, side effects, and safety considerations for diabetes and weight management in the U.S. and Canada.